Lymphotoxin-alpha (LT),
Introduction
Chronic lymphocytic leukemia (CLL), the most common adult leukemia observed in Western societies, is a malignancy of relatively mature B cells. Patients are characterized by high numbers of circulating clonal B cells, resulting from the transformation and clonal expansion of a single B lymphocyte within the CD5 + subset. 1, 2 Many cytokines, including TNF-␣, IL-2, and IL-7 have been suggested to be involved in the induction or regulation of B-CLL proliferation. [3] [4] [5] Lymphotoxin-alpha (LT) is a soluble product of activated lymphocytes that was first defined by its cytotoxic activity against fibroblasts. 6 LT is now known to be produced by activated type I CD4 + T helper lymphocytes, CD8 + lymphocytes, and certain B-lymphoblastoid cell lines. 7 The gene encoding human LT is located on chromosome 6, upstream of the evolutionarily related gene encoding TNF within the major histocompatibility complex. LT and TNF are structurally related molecules and share many common biological features. 8 Studies of natural functions of LT by production of an LT-deficient mouse strain suggest an essential role for LT in the normal development of peripheral lymphoid organs. 9 Mice deficient in LT have no morphologically detectable lymph nodes or Peyer's patches, although the thymus appears to be normal. Within the white pulp of the spleen, there is a failure of normal segregation of B and T cells, and lymphocytes positive for immunoglobulin M are present in increased numbers in both the spleen and peripheral blood. 9 Moreover, LT has been found to be an autocrine growth factor for EBV-infected B cell lines. 10 In this report we analyzed the potential role of LT in CLL, a low-grade B cell malignancy. We found that the malignant B-CLL cells from all 11 patients investigated constitutively produced LT. Proliferation of B-CLL cells is stimulated by LT and inhibited by antisense LT oligonucleotides. Moreover, it appears that LT prevents apoptosis of the malignant B-CLL cells.
Materials and methods

Cells
Peripheral blood samples were obtained from 11 patients fulfilling diagnostic and immunophenotypic criteria for common B cell CLL at the Medical Center of the University of Freiburg. The medium age of the patients was 61, ranging from 51 to 77 years. The clinical stage of the untreated patients ranged from Rai stage 1 to stage 4. Eight patients were male and three female. Blood was anticoagulated with heparin. Mononuclear cells were isolated by Ficoll-Hypaque (Pharmacia, Freiburg, Germany) density-gradient centrifugation. Plastic adherent cells were removed by incubation of the cell suspension on Petri culture dishes (Nunc, Wiesbaden, Germany) for 90 min at 37°C. The resulting cell population was depleted of T-cells by rosetting for 60 min at 4°C with neuraminidase-treated sheep RBCs. Non-rosetting cells were harvested from the interface of a second Ficoll gradient. The number of residual monocytes and T cells were determined by immunofluorescence with CD14 and CD3. All leukemic B cell populations used in our experiments had less than 1% CD3 + and CD14 + cells.
Cell surface markers and reagents
The mAbs used to determine immunophenotype were CD3, CD4, CD5, CD8, CD10, CD14, CD19, all of which were obtained from Becton Dickinson (Heidelberg, Germany). PCA-1 (CD27) and antibodies against cytoplasmic immunoglobulins and surface immunoglobulin anti-, anti-, anti-␥ and anti-␦ originated from Coulter (Krefeld, Germany obtained from R&D Systems (Minneapolis, MN, USA). This specific LT assay has a high sensitivity with a minimum detectable dose of 7 pg/ml. The LT sense oligodeoxynucleotide used in cell cultures was 5′-CCATGACACCACCTG-3′, where the ATG corresponds to the start of translation. The LT antisense was 5′-CAGGTGGTGTCATGG-3′ (complimentary to the sense oligonucleotide). Both were purified by FPLC and used at concentrations of 15 M, which were added to the cultures every 24 h.
The rabbit anti-human lymphotoxin antibody for FACS was obtained from Genzyme (Cambridge, MA, USA). Isolation of RNA Polyadenylated RNA was purified using the QuickPrep Micro mRNA purification kit (Pharmacia). The RNA from 10 6 cells was then dissolved in 30 l water, and 10 l were used for cDNA synthesis. The first-strand cDNA synthesis was carried out according to the SuperScript preamplification system Table 2 Induction of LT by TPA in cultured B-CLL cells (Gibco BRL, Eggenstein, Germany) using random hexamers. Generally, 5 l of cDNA were used as a template for amplification in the PCR. Primers for LT were 5′-ATG ACA CCT GAA CGT CTC TTC-3′ and 5′-C GAA GGC TCC AAA GAA GAC AGT ACT-3′, the expected size of the PCR product was 610 bp, and restriction enzyme PstI produced fragments of 477 and 133 bp. Primers were purchased from Clontech Laboratories (Palo Alto, CA, USA). Primers for LT-beta were 5′-CTC TAC TGT CTC GTC GGC TAC C-3′ and 5′-GCT TTC CAT TCT TTA TTT TCA TCA-3′; the expected size of the PCR product was 466 bp. Standard PCR was performed with Ampli Taq DNA polymerase (Perkin Elmer Cetus, Norwalk, CT, USA). After 35 cycles of PCR, 10 l of each 50 l sample was subjected to separation by agarose gel electrophoresis and stained with ethidium bromide.
Isolation of cell subsets
Analysis of apoptosis
Apoptosis was studied by light microscopy and by DNA gel electrophoresis. Cytocentrifuge preparations were stained with Wright-Giemsa for light microscopy analysis of apoptosis. 2 × 10 6 cells were assayed for DNA fragmentation after 48 h of culture as previously described. 11 Briefly, mononuclear cells were centrifuged at 500 g for 10 min. The cell pellet was lysed by adding 0.5 ml of hypotonic lysing buffer (10 mmol/l Tris, pH 7.4; 1 mmol/l EDTA; 0.2% Triton X-100) followed by gentle mixing. The lysates were immediately centrifuged at 11 000 g for 10 min to separate intact from fragmented chromatin. Supernatants and pellets were precipitated in separate microfuge tubes for 16-48 h at −20°C in 50% iso- propanol and 0.5 mol/l NaCl. The precipitates were collected by centrifugation at 11 000 g for 10 min, air dried, resuspended in TE buffer and heated at 55°C for 10 min. Electrophoresis was continued for 3 h at 20 V. Subsequently, the gels were incubated in TBE buffer containing DNase-free RNase A at 37°C for 3 h to digest RNA, stained with ethidium bromide, washed, and photographed. In this DNA fragmentation assay, intact chromatin and oligonucleosomal fragment are separated by centrifugation. Therefore, in the absence of apoptosis, the gel lane with the corresponding supernatant DNA appears empty.
11
Culture conditions and proliferation assay
The rate of DNA synthesis of CLL cells was measured by 3 HTdR uptake. 6 × 10 5 cells were seeded in triplicate in flat-bottom microtiter wells (Nunc) in a total volume of 200 l RPMI 1640 (Gibco, Karlsruhe, Germany) supplemented with 10% heat-inactivated fetal calf serum. Cultures were incubated up to 144 h at 37°C, 5% CO 2 and 98% humidity, and were pulsed with 1 Ci 
LT Assay
LT secretion by B-CLL cells was determined in culture supernatants using a Quantakine ELISA from R&D Systems, Wiesbaden, Germany. The sensitivity of the test was Ͻ16 pg/ml.
Results
LT mRNA expression in neoplastic B cells from CLL patients LT cytokine expression was examined by PCR to determine whether LT was consistently expressed in cells from patients with CLL. This analysis showed that LT was expressed in cells from 11 out of 11 CLL patients tested. The LT PCR product migrated in agarose gel electrophoresis to the approximate size predicted for the mRNA-derived template (610 bp; Figure 1, lane 2) . Digestion of the LT PCR product with the restriction enzyme PstI revealed two fragments as expected from the cDNA sequence (477 bp and 133 bp; Figure 1 , lane 3). To rule out contaminating DNA as a source of template, we performed PCR using RNA without prior reverse transcription. No LT product was evident in the absence of a cDNA template. A PCR product derived from genomic DNA would be expected to consist of 943 bp since the reverse and forward primers for LT span two introns of genomic sequence consisting of 86 bp and 247 bp. Thus, LT was expressed in cells + cells were clearly identified as a major population and were sorted to a purity of more than 99%. The cells were then washed and processed for the isolation of RNA. PCR demonstrated that only the subset consisting of the leukemic population expressed LT mRNA (data not shown). In addition, we examined the expression of LT-beta by PCR and it was not detected in any of the eight CLL cases tested.
Suppression of the LT mRNA expression by hydrocortisone B-CLL cells underwent rapidly programmed cell death after addition of hydrocortisone to the cell cultures. 12 Under the assumption that LT is an essential endogenous growth factor for the neoplastic B cells, we then analyzed whether hydrocortisone abrogated the LT mRNA expression. Using RT/PCR amplification we showed that LT mRNA expression was absent in the hydrocortisone-treated cultures after an incubation time of 12 h, whereas LT mRNA expression could be detected in the unstimulated B-CLL cultures for up to 6 days ( Figure 2 ). Similar amounts of beta-actin mRNA were amplified in parallel experiments in the cultures with or without
Figure 3
Reduction of DNA synthesis by addition of antisense LT oligonucleotides to cultures. Reduction of DNA synthesis and induction of apoptosis by antisense LT Addition of recombinant LT to purified B-CLL cells suggested that B-CLL cells can be growth stimulated by exogenous LT (Figure 3) . To test further the function of endogenously produced LT on the DNA synthesis, we used antisense LT oligonucleotides. Daily addition of antisense LT oligonucleotides (15 M) to the cultures reduced the DNA synthesis as measured by 3 H-TdR incorporation ( Figure 3 and Table 1 ). Addition of LT and antisense LT oligonucleotides in conjunction with the B-CLL cultures reversed the inhibited DNA synthesis caused by antisense LT oligonucleotides (Figure 3) . However, sense LT (15 M) oligonucleotide did not significantly influence DNA synthesis (Table 1) . Furthermore, B-CLL cells cultured with antisense LT oligonucleotides showed characteristic features of apoptosis. After 48 h, 30% of cells showed morphologic evidence of apoptosis such as nuclear fragmentation and loss of cell volume. At the same time, we observed degradation of DNA into fragments (Figure 4 ).
Figure 4
Endogenously produced LT inhibits DNA fragmentation in B-CLL cells. The cells (2 × 10 6 /ml) were cultured for 48 h with medium + 10% FCS, sense LT oligonucleotides (15 M, sLT), antisense LT oligonucleotides (15 M, asLT), and hydrocortisone (1 M, HC). The DNA ladder was performed as described in Ref. 11 . Intact chromatin and oligonucleosomal fragments are separated by centrifugation. Therefore, in the absence of apoptosis, the gel lane with the corresponding supernatant DNA appears empty.
Secretion of LT after stimulation
The supernatants from B-CLL cultures were examined for the ability of B-CLL cells to constitutively secrete LT. In contrast to our results with PCR, LT could not be detected by ELISA in the supernatant of unstimulated cultures in the seven patients examined over a culture period of 1-3 days. Intracellularly, LT has been observed reacting at low concentrations, therefore, the level of LT secreted by B-CLL may be too low to measure by ELISA. Thus, we investigated the possibility that B-CLL cells produce LT after stimulation. Phorbolesther TPA, which has been shown to induce LT and prevent apoptosis of B-CLL cells, 11 was used at a final concentration of 2 × 10
to induce LT secretion by the B-CLL cells. TPA induced up to 392 pg/ml LT in B-CLL cultures (3 × 10 6 cells/ml) from seven of seven patients after an optimal incubation time of 48 h ( Table 2 ). Furthermore, we tested for membrane-bound LT heterotrimers by using FACS and Ab against LT, but no membrane-bound LT was detected on B-CLL cells of the eight cases tested.
Discussion
The production of LT is restricted to lymphocytes or cells derived from lymphoid progenitors.
7 EBV-infected lymphoblastoid cell lines produce LT constitutively and the autonomously produced LT serves as a growth factor for EBVinfected B cells stimulating their growth in an autocrine fashion. 10 In this report, we have examined the role of LT in B-CLL cells that had been isolated from 11 patients. We found that the mRNA for LT was expressed in the leukemic B cells of all patients. In contrast, LT mRNA could not be detected in mononuclear cells or B cells from healthy individuals. The detection of LT in the supernatant after stimulation indicated that LT mRNA is actually translated into protein by the leukemic B cells. Our data suggest that LT may be produced by the malignant lymphoma clone and act as an autocrine growth factor stimulating proliferation of B-CLL growth. Similar findings have been previously reported for TNF-␣. 13 In contrast to TNF-␣ secretion, LT mRNA expression appears to be observed in every single case examined and its spontaneous production appears to be rather low. This suggests that LT may act in an autocrine fashion in B-CLL cells. Moreover, our data show that antisense LT oligonucleotides inhibit B-CLL proliferation in all five patients examined. Importantly, this blocking can be reversed by exogenous LT, suggesting that LT is a growth factor for B-CLL cells independent of TNF-␣. LT and TNF-␣ share a 30% sequence homology and possess many overlapping biological activities.
14 Also, TNF-␣ and LT use common receptors. 15 In most cases, TNF-␣ has been shown to stimulate proliferation of malignant B cells, 4,13 but rarely to inhibit B cell growth. 16 TNF-␣ and LT have divergent effects on proliferation of hairy cell leukemia B cells, with TNF-␣ being stimulatory while LT is inhibitory. 17 In contrast, LT promoted growth of lymphoblastoid B cell lines while TNF-␣ partially reversed the stimulatory effect of LT. 10 Since LT expression was only detected in leukemic B cells but not in B cells from normal donors, LT expression might be related to leukemic transformation. The mechanisms underlying the aberrant lymphoproliferative stimulus in chronic leukemias, such as B-CLL, remain unclear. A critical event in the process of B cell immortalization may be the initiation of an autocrine loop, where cells produce growth factors that support their own proliferation. 18 Aberrant production of a growth factor by B-CLL cells has also been shown for IL-7. 5,19 TNF-␣/LT binding proteins are greatly increased in the sera of B-CLL patients. 20 Our data show that the malignant cell clone secretes these soluble TNF/LT-receptors (Digel et al, unpublished results).
Endogenous production of LT might trigger release of soluble LT receptors by the malignant cells. These soluble receptors bind and neutralize TNF-␣ and LT, and thus, could compete with cell-bound receptors for the ligand. This could partially explain why LT levels in sera of patients and culture supernatants appear to be low and LT could not be detected in the supernatant without stimulation.
B-CLL cells express both types of TNF receptors. 21 Membrane-bound LT heterotrimers could not be detected on the B-CLL cells. Expression of LT-beta is a prerequisite in the formation of LT heterotrimers on the cell surface. 22 Furthermore, we could not detect LT-beta in any of the cases tested. It seems unlikely that B-CLL express lymphotoxin-beta-specific receptors.
Programmed cell death appears to be regulated by cytokines acting as survival signals. 23 B-CLL cells cultured with asLT showed a DNA ladder characteristic of apoptosis. Thus, autocrine secretion of LT might delay apoptosis and extended survival of malignant clones similar to what has been shown for IFN-␥. 24 Glucocorticoid hormones, commonly used to treat patients with B-CLL, abrogated the LT mRNA expression and induced apoptosis. A possible mechanism that could explain this finding is abrogation of LT mRNA expression by glucocorticoids. Factor deprivation resulting in apoptosis has been well documented in other systems, such as hematopoietic colony-stimulating factors. 25 In summary, our data document autocrine aberrant secretion of LT by B-CLL cells and suggest that autocrine LT production could result in clonal expansion of B-CLL cells by prevention of programmed death. 26 Suppression of an endogenous cytokine pathway might be an important tool for treatment of low-grade lymphomas in the future.
